Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01074034 · ClinicalTrials.gov registry record · NA
REASSURE AV Registry
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 211
- Enrollment target
NCT01074034: Completed NA study, sponsored by Boston Scientific Corporation.
NCT01074034 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 211 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01074034, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 211 participants
- Enrollment target
Study Summary
Long term follow-up to monitor safety for patients implanted with a B301 ASSURE device.
Primary Outcome
Incidences of ventricular shock therapy up to three months post implant. Rescue shocks are intended for the treatment of cardiac arrhythmias detected in the ventricle at rates greater than 220 bpm, including arrhythmias that originate in the atria if they are conducted at rates greater than 220 bpm as this can be life threatening if persistent. Shocks delivered for other reasons will be considered inappropriate shocks.
Interventions
- DEVICE AV Therapy Assessment-B301 investigational device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2006-04 |
| Est. Completion | 2011-06 |
| Phase | NA |
What the finished NCT01074034 record still lists
NCT01074034 is an interventional study that assigns participants to a tested intervention. The registered 211 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 1 intervention - of which AV Therapy Assessment-B301 investigational device is the first listed.
NCT01074034 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01074034 about?
NCT01074034 is a clinical study titled "REASSURE AV Registry". Long term follow-up to monitor safety for patients implanted with a B301 ASSURE device.
What is the current status of trial NCT01074034?
This trial is currently completed. It is a NA study. The enrollment target is 211 participants. The study started on 2006-04. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01074034?
The interventions under investigation include: AV Therapy Assessment-B301 investigational device (DEVICE).
Who is sponsoring clinical trial NCT01074034?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01074034's enrollment target sits among peer trials
211 490th of 2000 higher than 1,511 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06698796 · 211 participants · Phase 3
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
- NCT04228978 · 212 participants · NA
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
- NCT04725721 · 212 participants · NA
Testing FIRST in Youth Outpatient Psychotherapy
- NCT06257576 · 212 participants · Phase 3
Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia